Luminex® Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.
AUSTIN, Texas , Dec. 6, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the fourth quarter of 2019 of $0.09 per share of common stock payable on January 15 , 2019 to stockholders of record as of the
AUSTIN, Texas , Nov. 25, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Harriss Currie , Senior Vice President of Finance and CFO, will participate in investor meetings and present at the Piper Jaffray 31 st Annual Healthcare Conference on Wednesday, December 4, 2019
